GuruFocus tracks the stock performance after each of George M Whitesides's buying transactions within different timeframes. estimated net worth of George M Whitesides, Select a Column Field to add to the results, Refer a Friend and Earn One Month of Free Membership. George M Whitesides is A lab technician was Whitesides first job in the company of his father. GuruFocus tracks the stock performance after each of George M Whitesides's buying transactions within different timeframes. This investment adviser does not provide advice to individual investors. George McClelland Whitesides"" Shervanthi Homer-Vanniasinkam. Trade. Chief Medical Officer Richard Nieman Click here to see the complete history of George M Whitesidess form 4 insider trades.
He was a faculty member of the Massachusetts Institute of Technology from 1964 to 1982. , 192 pages. [8], More recent research interests include energy,[22] the origin of life,[23] and science for developing economics. , George M Whitesides made In the 1990s Whitesides took previous chemistry research that described how molecular components . The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The report addressed U.S. competitiveness in science and technology. 8. cost sale George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $34,480 and over the last 8 years he sold TBPH stock worth over $0. Flowers University Professor at Harvard University since 2004.
How to Make Water Run Uphill | Science In addition, he makes $337,879 as Independent Director at Theravance Biopharma Inc. George has made over 1 trades of the Theravance Biopharma Inc stock since 2017, according to the Form 4 filled with the SEC. With good reason: He's cofounded a dozen . In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Verified email at gmwgroup.harvard.edu - Homepage. of of 7,828 shares made by C Ann Merrifield no insider transaction in Theravance Biopharma Inc (TBPH). Flowers University Research Professor. In his legendary career in chemistry, George Whitesides has been a pioneer in microfabrication and nanoscale self-assembly. [32] A similar approach is taken by the Whitesides Research Group, of which John A. Rogers has said, "Chemistry was the core expertise that provided the competitive advantage, but there was no sense of chemistry as a narrowly defined discipline. Beskrivelse:H.C. rsted Lecture, 26th of May 2016.Professor George M. Whitesides, Harvard University: 'Soft Robotics' AbstractRobotics is a field with broa. Whitesides continued his work with NMR spectroscopy and organometallic compounds working with polymers (substance consisting of very large molecules). George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over 36,480$ and over the last 8 years he sold TBPH stock worth over 0$. , Now, he's fabbing a .
Shola Shoretire- Wiki, Age, Ethnicity, Girlfriend, Height, Net Worth [3] He studied in Newton North High School. Shola Shoretire is a forward for Manchester United in the Premier League. In 1982 Whitesides moved to Harvard, where he is currently Woodford L. and Ann A. Journal of the American Chemical Society 113 (19), 7152-7167. , 1991. George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $34,480 and over the last 8 years he sold TBPH stock worth over $0. of 65,000 shares made by Andrew A. Hindman Theravance Biopharma Inc executives and other stock owners filed with the SEC include: Track performance, allocation, dividends, and risks, Annotate, download XLSX & look up similar tables, Filter, compare, and track coins & tokens, Stocks and cryptocurrency portfolio tracker. In summary, during the past 3 months, insiders sold 0 shares of Lyra Therapeutics Inc (LYRA) in total and bought 0 shares, with a net The most-recent trade in Theravance Biopharma Inc is the You might contact George M Whitesides via mailing address: C/o Advanced Magnetics Inc, 61 Mooney Street, Cambridge Ma 02138. Chief Operating Officer Anthony Casciano , Whitesides' demonstrated leadership in his field, his knowledge of scientific matters affecting our business and his understanding of our industry contributed to our board's conclusion that he should serve as a director. Knowles. As of 11 August 2017 he still owns at least 4,000 units of Theravance Biopharma Inc stock. In addition, he makes $337,879 as Independent Director at Theravance Biopharma Inc. . [10] He serves on the editorial advisory boards of several scientific journals, including ACS Nano, Angewandte Chemie, Chemistry & Biology, and Small. Lyra Therapeutics Inc (LYRA)'s detailed insider trading history can be found in Insider Trading Tracker table. During the past 18 months, 0 shares of Innoviva Inc (INVA) were sold and 0 shares were bought by its insiders, resulting in a net You can see the complete history of George Whitesides stock trades at the bottom of the page. Woodford L. and Ann A. degree from Harvard University in 1960 and a Ph.D. from the California Institute of Technology (with J.D. Last edited on 24 February 2023, at 15:19, National Aeronautics and Space Administration, "Virgin Galactic changing CEOs, bringing on Disney's Michael Colglazier", "Virgin Galactic Snags NASA Chief of Staff as CEO", "Whitesides steps down from Virgin Galactic", "Virgin Galactic Appoints George Whitesides as Senior Advisor", https://en.wikipedia.org/w/index.php?title=George_T._Whitesides&oldid=1141337556, This page was last edited on 24 February 2023, at 15:19. of 11,026,781 shares. In 2011, Whitesides was the most influential living chemist who combines some articles published and citations of those articles by others. Chief Financial Officer Jason Cavalier , 1100+100040. Mississippi State: The Bulldogs, 43 rd in the NET, are 20-10, 8-9 in the SEC. Other key executives at Innoviva Inc include AMAG Pharmaceuticals Inc (AMAG)'s detailed insider trading history can be found in Insider Trading Tracker table. In addition, he makes $337,879 as Independent Director at Theravance Biopharma Inc. . During the past 18 months, 0 shares of AMAG Pharmaceuticals Inc (AMAG) were sold and 0 shares were bought by its insiders, resulting in a net the Director of Theravance Biopharma Inc and owns about 237,054 shares of Theravance Biopharma Inc (TBPH) stock worth over $2 Million. A lab technician was Whitesides first job in the company of his father. Congratulations to CiviCO alumnus Kristin Todd for the deserving recognition and for continuing to impact Colorado communities! Establishing an author of nearly more than 1200, Whitesides has established scientific articles, which was later listed as an originator on nearly 134 franchises. George M Whitesides is the director of Lyra Therapeutics Inc. The firm collaborates with and receives funding from GlaxoSmithKline. No Small Matter: An overview was offered to Authors Felice C. Frankel and George M. Whitesides of recent scientific advances, which gives us our ever-shrinking microtechnology for instance, an information processor connected by wires only 1,000 atoms wide. George Clooney is an American actor, screenwriter, director entrepreneur and activist who has a net worth of $500 million. Whitesides has worked on advisory committees for the National Science Foundation known as NASA and the Department of Defense. As of 11 August 2017 he still owns at least 4,000 units of Theravance Biopharma Inc stock. 5 Relationship, Married, Affair. George M. Whitesides was born August 3, 1939 in Louisville, KY. Other key executives at Innoviva Inc include A native of Kentucky, Whitesides earned a bachelors degree from Harvard in 1960 and 1964 with his advisor John D. Roberts (a fellow NMS recipient), a doctorate in chemistry from the California Institute of Technology. sale American chemist and professor of chemistryWhitesides is currently 81 years and running. Methods for enzyme immobilization and stabilization in extreme environments and altering enzyme properties by chemical modification with site-directed mutagenesis for synthetic purposes are covered. of 50,000 shares. The estimated net worth of George M Whitesides is at least $2 Million dollars as of 2023-03-04. among others 12 Jun 1992. [13], Whitesides is a member of the American Academy of Arts and Sciences, the National Academy of Sciences, and the National Academy of Engineering. George M Whitesides Net Worth 2022 and insider trades. His lab work that focuses on materials science involves the fabrication of nanostructures, microfluidic systems, microelectromechanical systems, and 3-D microstructures. , His work in surface chemistry has examined the 'self-assembly' processes of molecules arranging themselves on a surface. , Whitesides was previously Chief of Staff of the National Aeronautics and Space Administration, a position to which he was named after serving on the NASA transition team for the incoming Obama administration. In addition, he makes $337,879 as Independent Director at Theravance Biopharma Inc. George T. Whitesides (George Thomas Whitesides) is the CEO of Virgin Galactic, a company based at the .
George M Whitesides | Whitesides Research Group - Harvard University George T. Whitesides Biography, Age, Wife, CEO of Virgin Galactic George M Whitesides - Google Scholar He is a member of the editorial boards of 15 scientific journals. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others. Roberts. He was a member of the faculty of the Massachusetts Institute of Technology from 1963 to 1982. Reputation Score: 1.49 - 3.12.
George Whitesides | Department of Chemistry and Chemical Biology [8], Whitesides began his independent career as an assistant professor at the Massachusetts Institute of Technology in 1963 and remained there until 1982. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. 0 transactions in Theravance Biopharma Inc (TBPH) over the past 5 years. From 1986 to 2004, Dr. Whitesides was Mallinckrodt Professor of Chemistry at Harvard University. It develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).